BL
AZN icon

BCWM LLC’s AstraZeneca AZN Stock Holding History

BCWM LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,871
Closed -$912K – 69
2016
Q3 		$912K Sell
13,871
-240
-2% -$15.7K 0.42% 56
2016
Q2 		$852K Buy
14,111
+217
+2% +$12.6K 0.41% 56
2016
Q1 		$783K Buy
13,894
+21
+0.2% +$1.26K 0.44% 58
2015
Q4 		$942K Sell
13,873
-145
-1% -$9.51K 0.57% 56
2015
Q3 		$893K Buy
14,018
+235
+2% +$15.5K 0.44% 76
2015
Q2 		$879K Buy
13,783
+478
+4% +$32.7K 0.37% 74
2015
Q1 		$9.11M Buy
13,305
+662
+5% +$46K 0.42% 66
2014
Q4 		$8.9M Sell
12,643
-55
-0.4% -$3.94K 0.43% 64
2014
Q3 		$9.07K Buy
12,698
+152
+1% +$11.1K 0.46% 66
2014
Q2 		$933K Sell
12,546
-26,788
-68% -$1.94M 0.48% 65
2014
Q1 		$2.55M Sell
39,334
-9,220
-19% -$595K 1.34% 33
2013
Q4 		$2.88M Sell
48,554
-414
-0.8% -$22.5K 1.63% 25
2013
Q3 		$2.54M Sell
48,968
-4,707
-9% -$236K 1.55% 26
2013
Q2 		$2.54M Buy
+53,675
New +$2.73M 1.54% 28

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BCWM LLC's AZN Position: Q4 2016 in Review

BCWM LLC sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 13,871 shares — an estimated $912K sold.

BCWM LLC first reported a position in AZN in Q2 2013 and held it in 14 quarters. The position peaked at $9.11M in Q1 2015. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

  • BCWM LLC reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
  • BCWM LLC sold 13,871 AstraZeneca shares in Q4 2016, an estimated $912K.
  • BCWM LLC first reported a position in AstraZeneca in Q2 2013 and held it in 14 quarters.
  • BCWM LLC's AstraZeneca position peaked at $9.11M in Q1 2015.
  • 450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on BCWM LLC's 13F filing for Q4 2016, filed 9 Feb 2017.